Total Payments
$5,870
2024 Payments
$16.62
Companies
38
Transactions
250
Medicare Patients
887
Medicare Billing
$80,944
Payment Breakdown by Category
Food & Beverage$5,787 (98.6%)
Other$83.10 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,787 | 246 | 98.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83.10 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,051 | 32 | $0 (2023) |
| ABBVIE INC. | $643.11 | 40 | $0 (2024) |
| GENZYME CORPORATION | $569.79 | 17 | $0 (2022) |
| Amgen Inc. | $457.26 | 23 | $0 (2022) |
| Biogen, Inc. | $447.88 | 17 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $304.26 | 15 | $0 (2021) |
| Allergan, Inc. | $213.84 | 10 | $0 (2022) |
| UCB, Inc. | $211.43 | 7 | $0 (2021) |
| UPSHER-SMITH LABORATORIES LLC | $179.53 | 7 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $154.45 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.62 | 1 | ABBVIE INC. ($16.62) |
| 2023 | $344.68 | 14 | AbbVie Inc. ($215.16) |
| 2022 | $746.97 | 22 | Novartis Pharmaceuticals Corporation ($323.26) |
| 2021 | $3,169 | 155 | AbbVie Inc. ($310.83) |
| 2020 | $984.78 | 50 | Novartis Pharmaceuticals Corporation ($162.53) |
| 2019 | $607.99 | 8 | GENZYME CORPORATION ($272.42) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/01/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $97.69 | General |
| Category: Neurology | ||||||
| 05/31/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug), BIJUVA, IMVEXXY | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 11/01/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $89.79 | General |
| Category: Neuroscience | ||||||
| 06/01/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $42.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/04/2022 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/03/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 184 | 207 | $51,630 | $14,288 |
| 2022 | 4 | 235 | 248 | $59,176 | $16,177 |
| 2021 | 6 | 298 | 349 | $107,602 | $35,179 |
| 2020 | 4 | 170 | 199 | $51,877 | $15,301 |
Total Patients
887
Total Services
1,003
Medicare Billing
$80,944
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 96 | $20,027 | $6,616 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 31 | $9,169 | $2,793 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 47 | $7,480 | $2,004 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $8,330 | $1,660 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,624 | $1,215 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 117 | $24,601 | $6,865 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 52 | $14,177 | $5,260 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $11,641 | $2,436 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 53 | $8,757 | $1,615 | 18.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 115 | 115 | $47,725 | $14,660 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 117 | $21,762 | $7,022 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 58 | $15,834 | $5,798 | 36.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $9,414 | $3,218 | 34.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 18 | $6,588 | $2,615 | 39.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $6,279 | $1,865 | 29.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 59 | 59 | $24,485 | $7,750 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 44 | $6,952 | $2,428 | 34.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 50 | 50 | $10,300 | $2,028 | 19.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $5,208 | $1,685 | 32.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 18 | 18 | $4,932 | $1,411 | 28.6% |
About Dr. Carrie Downey, DO
Dr. Carrie Downey, DO is a Neurology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1396164042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carrie Downey, DO has received a total of $5,870 in payments from pharmaceutical and medical device companies, with $16.62 received in 2024. These payments were reported across 250 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,787).
As a Medicare-enrolled provider, Downey has provided services to 887 Medicare beneficiaries, totaling 1,003 services with total Medicare billing of $80,944. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Student in an Organized Health Care Education/Training Program
- Location Bangor, ME
- Active Since 04/09/2014
- Last Updated 05/19/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1396164042
Products in Payments
- KESIMPTA (Drug) $607.44
- Aimovig (Biological) $457.26
- NURTEC ODT (Drug) $329.98
- QULIPTA (Drug) $325.37
- AUBAGIO (Drug) $297.37
- UBRELVY (Drug) $263.18
- VUMERITY (Drug) $220.45
- GOCOVRI (Drug) $135.76
- GILENYA (Drug) $135.64
- TOSYMRA (Drug) $132.74
- ZEPOSIA (Drug) $123.22
- DISEASE STATE (Drug) $122.50
- GAMMAGARD (Biological) $118.11
- MS DISEASE STATE (Drug) $116.56
- Fycompa (Drug) $115.86
- RYTARY (Drug) $114.13
- EMGALITY (Drug) $112.38
- VYEPTI (Biological) $111.52
- BOTOX (Biological) $106.46
- AIMOVIG (Biological) $101.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bangor
Markos Poulopoulos, M.d, M.D
Neurology — Payments: $8,705
Neurology $8,705
Enrique Feoli, M.d, M.D
Neurology — Payments: $6,994
Neurology $6,994
Mirna Hajjar
Neurology — Payments: $1,032
Neurology $1,032
Bakhtier Nurmukhamedov, M.d, M.D
Neurology — Payments: $290.15
Neurology $290.15
Tarek Wazzan, M.d, M.D
Neurology — Payments: $200.54
Neurology $200.54
Dr. Karl Sanzenbacher, M.d, M.D
Neurology — Payments: $162.77
Neurology $162.77